HOTH - Why Hoth Therapeutics Shares Are Rising Today | Benzinga
Hoth Therapeutics, Inc. (NASDAQ: HOTH) shares are trading higher after the company announced the expansion of its FDA-cleared first-in-human clinical trial for cancer patients of HT-001 at the University of Miami.
This First-in-Human (FIH) Phase 2a clinical trial of HT-001 for the treatment of skin toxicities associated with Epidermal Growth Factor ...